Dag Pavic, MD - Hollings Mammography Center

Dr. Nancy DeMore is a board-certified breast surgical oncologist and is the BMW endowed chair in cancer research at MUSC Health. Her clinical interests are breast cancer in young women, breast conservation therapy, breast sarcoma, inflammatory breast cancer, oncoplastic surgery, sentinel node biopsy, and skin and nipple-sparing mastectomy.As a surgeon, Dr. DeMore has played an integral role in the evaluation of minimally invasive techniques that have changed the standard of care for patients who require sentinel lymph node biopsy. Furthermore, she has expanded the indications for breast conservation by advancing the use of neoadjuvant chemotherapy (cancer-killing drugs taken before primary therapy).Dr. DeMore is also a physician-scientist with extensive research experience in developing new therapies for breast cancer. She has been a co-investigator on 11 active clinical trials and 24 completed clinical trials, which have led to clinical advances in the care of breast cancer patients, in particular, those with metastatic breast cancer. For more than 25 years, she has investigated tumor angiogenesis (the growth of new capillary blood vessels, which provide tumors with oxygen and nutrients.) Her lab focuses on discovering novel factors that stimulate this growth and developing new drugs that block these factors and therefore inhibit tumor growth. Dr. DeMore has been appointed to a six-year term on the NIH Oncology 2, Translational Clinical IRG, Cancer Immunopathology and Immunotherapy Study Section. Her hope is that over the next 20 years, she will have helped contribute to excellent patient care, advancement of less-invasive survival techniques, and development of novel therapies that will improve survival for patients with metastatic disease.Dr. DeMore obtained her medical degree from Chicago Medical School. She completed her residency at Boston University Medical Center, a cancer research fellowship at Harvard Medical School, and fellowship training at Memorial Sloan Kettering Cancer Center. Dr. DeMore practiced as a professor of surgery at the University of North Carolina-Chapel Hill for 13 years.

Carolyn D. Britten, MD is a highly skilled surgical oncologist based in Charleston, SC, specializing in the treatment of cancer. With expertise in surgical procedures and a focus on patient care, Dr. Britten provides compassionate and comprehensive care to her patients. As a female physician fluent in English, Dr. Britten is dedicated to delivering personalized treatment plans tailored to each patient's unique needs. With offices at MUSC Hollings Cancer Center, she is committed to providing exceptional care and support to individuals and families affected by cancer.Generated from the website

Dr. Benjamin Toll is a licensed clinical psychologist, a professor of Public Health Sciences and Psychiatry, Co-Director of the Lung Cancer Screening Program, and Chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, and Director of the Tobacco Treatment Program at the Medical University of South Carolina. He specializes in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviors.Dr. Toll has received grants from the National Institutes of Health, including the National Cancer Institute, and he is an author of over 110 peer-reviewed publications relating to nicotine and tobacco research, including several clinical practice guidelines and policy statements from US medical societies. He has served as an author for the American Association for Cancer Research (AACR) on a policy statement encouraging physicians to provide tobacco treatment for cancer patients,Dr. Toll's NCI funded research has focused on testing novel smoking cessation treatments and he has conducted numerous clinical trials in this regard. Many of his studies have investigated promotion of smoking cessation through novel message framing and motivational interventions, including those delivered via telephone and in person. Dr. Toll has tested several pharmacological and counseling interventions, and he also has expertise in the measurement of tobacco use and tobacco related syndromes (e.g. withdrawal)